H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 112,644. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lansing clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lansing storefront.
Chronic Wound Treatment That Works in Lansing, MI for clinics & physicians. Effective chronic wound treatm… Compliance support & pricing — contact Hawk Medical.
Lansing is a city under 250k (112,644 Census). CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Adult arthritis here is 26.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Chronic Wound Treatment That Works notes (how the product actually works)J8 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Lansing is 12.4% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Lansing warehouse or a five-star local review. What you get is chronic wound treatment from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J8, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 39.9%; arthritis is 26.9%. That is place-level BRFSS modeling, not a clinic census and not a Lansing trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Michigan.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Michigan compliance risk.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Michigan audit trail stays clean.
If you operate in Michigan and another MAC state, say it on the first call. J8 will not port 1:1. We would rather split utilization than watch a sister clinic copy Lansing tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Lansing, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lansing is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Lansing — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Lansing. Useful for joint-program math; still needs a diagnosis and privileging.
No Lansing storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.